Tag: Vaccines
FDA Advisers Weigh COVID-19 Booster Shots for Fall
Vaccine experts still guessing at what the ever-changing pandemic will bring
Cardiac Complications Up After SARS-CoV-2 Infection Versus Vaccines
Incidence of cardiac outcomes after mRNA COVID-19 vaccination highest in males aged 12 to 17 years, but risk 1.8 to 5.6 times higher after infection
Vaccination Offers Extra Protection After SARS-CoV-2 Infection
Two studies show additional protection against reinfection and COVID-19-linked hospitalization with vaccination
FDA Panel Meets to Craft Future Vaccine Strategy
No official vote is planned, and no specific vaccine products will be discussed
COVID-19 Vaccination Early in Pregnancy Not Linked to Fetal Anomalies
Vaccination within teratogenic window not linked to presence of congenital anomalies identified on ultrasonography
BNT162b2 Prevents Critical COVID-19 in Children and Adolescents
During omicron-predominant period, effectiveness of two doses against hospitalization 68 percent for children, 40 percent for adolescents
Risk for Acute MI Not Increased With Two-Dose HepB-CpG Vaccine
Noninferiority study shows no increased risk for acute MI with two-dose HepB-CpG vaccine versus three-dose HepB-alum vaccine
Physician’s Briefing Weekly Coronavirus Roundup
SARS-CoV-2 Vaccination Seems Safe After MIS-C
No major adverse events seen among 15 children with MIS-C who were subsequently vaccinated against SARS-CoV-2
Universal HepB Vaccination Recommended for Adults Age 19 to 59
Those aged 60 years or older with risk factors should receive vaccine; those without risk factors should be offered vaccine
